Medtronic plc — Director's Dealing 2018

Aug 29, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-08-28

Reporting Person: Kuntz Richard (SVP & Chief Medical & Science)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-28	Ordinary Shares	M	41227	$38.81	Acquired	152579	Direct
2018-08-28	Ordinary Shares	S	47176	$95.8769	Disposed	105403	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-28	Stock Option (Right to Buy)	$38.81	M	41227	Disposed	2022-07-30	Ordinary Shares (41227)	Direct

Footnotes

F1: The price is a weighted average price. These shares were sold in multiple transactions in prices ranging from $95.82 to $95.9850, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4.

F2: This option to purchase 41,227 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 41,227 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.